Introduction
Cardiac output is monitored in critically ill patients to assess cardiac function with the primary goal of maintaining adequate tissue perfusion. The value of the pulmonary artery catheter (PAC), the standard technique for more than 30 years, has been questioned recently. Its impact on outcome is a matter of debate with conflicting study results published [1 ,2] . Some of the discrepancies may rather be explained by patient selection (i.e. indications) and different treatment protocols (or the lack thereof) than by the type of monitoring per se [3 ] . Today, several less invasive cardiac output monitoring techniques are commercially available. They have been shown to be able to adequately replace the PAC under certain clinical circumstances. Furthermore, these techniques may be used more widely, mainly in an earlier assessment of patients at risk for hemodynamic instability and therefore may be applied to a larger patient population. Large outcome studies using less invasive cardiac output (CO) monitoring devices for hemodynamic optimization are still lacking. The concept of a 'goal-directed hemodynamic therapy', applied to selected patient groups at risk of inadequate tissue perfusion, is promising, however [4] [5] [6] .
In daily routine, deciding which CO measurement monitor to use -excluding the financial aspect -depends on the following factors:
(1) knowledge of the technical principles; (2) ability of a convenient routine handling; (3) safety issues -because increasing invasiveness raises the risk of complications; (4) validation data -whether the particular device is accurate and reliable compared with the PAC and if published data can be applied to the current clinical setting; (5) additional hemodynamic variables.
The aim of this article is to review the currently available CO measurement methods. This information should help in selecting the appropriate technique to measure CO in a particular clinical setting. Please note that the specific features of each discussed technique are summarized in Table 1 , and the most recent validation data using the intermittent thermodilution technique (ITD) as a reference method are given in Table 2 .
Pulmonary artery catheter
None of the available CO measurement techniques has been better investigated than the PAC and complications related to this technique are well known [43] . An indepth review is therefore beyond the scope of this article. Briefly, CO measurement by ITD using iced water as indicator is based on the Stewart-Hamilton principle (Fig. 1) . It is often considered a 'clinical standard' for CO assessment as there is no true reference technique for the clinical determination of CO. The pitfalls with its use, however, related to operator, indicator and patient pathologies (valves, shunts) have to be emphasized [44] .
Continuous CO (CCO) assessment in contrast avoids some of these limitations. The thermal filament emits heat in a binary on-off sequence. The resulting pulmonary artery temperature changes are measured via a distal thermistor and matched with the input signal. Cross correlation of in and output signals then allows CO values to be produced in intervals from the resulting thermodilution wash-out curve. These values are averaged for a delayed display of CCO readings resulting in response times of several minutes after induction of CO changes [i.e. for Opti-Q (Abbott, Abbott Park, Illinois, USA) and Vigilance (Edwards LifeSiences, Irvine, California, USA) catheters] [45] . Recently, a so-called fast response CCO catheter has been re-introduced to the market (truCCOMS; Omega Critical Care, East Kilbride, UK). This device continuously calculates the energy used by a heating filament to maintain a specified blood temperature gradient between two thermistors, hence allowing a more instantaneous CCO monitoring. The majority of recently published studies comparing CCO with ITD showed an acceptable accuracy for this technique (including truCCOMS) [7, 8, 10, 11] . Accuracy, however, is decreased during large temperature shifts (i.e. after cardiopulmonary bypass) [9, 46] . Moreover, despite a fast response time, the ability of the truCCOMS catheter to reliably track rapid hemodynamic changes seems to be limited [10] .
The most relevant additional hemodynamic variables accessible by the PAC are conventional filling pressures, pulmonary artery pressures and mixed venous oxygen saturation. The relevance of filling pressures has been challenged in the last few years, because different studies revealed a lack of correlation between changes of central venous/pulmonary capillary wedge pressure and stroke volume or echocardiographic preload assessment [47] [48] [49] . Therefore, volumetric preload estimation by transpulmonary artery thermodilution as a superior alternative has been recommended, whereas volumetric preload estimation derived from the PAC may be less important [48] . The PAC, however, is still indicated in severely ill patients when additional monitoring of pulmonary artery pressures and mixed venous oxygen saturation is desirable. It is also indicated in situations in which less invasive techniques are contraindicated or fail to provide accurate CO values.
Pulse wave analysis
Pulse wave analysis relies on the principle to predict vascular flow by means of the arterial pressure waveform, which is a result of an interaction between stroke volume and the systemic vascular system. Thus, resistance, compliance and characteristic impedance at the site of signal detection have to be considered. Different models are used to address these issues in the currently available pulse wave analysis devices [PiCCOplus (Pulsion Medical Systems, Munich, Germany); PulseCO (LiDCO Ltd, London, UK); FloTrac/Vigileo (Edwards LifeSiences)].
For the PiCCOplus system, aortic pressure waveforms are recorded typically via femoral access by a thermistor tipped arterial catheter. Cardiac output is then calculated on a beat-to-beat basis using an algorithm measuring the area under the systolic part of the pressure waveform (Fig. 2) after calibration by transpulmonary thermodilution. This technique has been repeatedly validated against ITD [12] [13] [14] . The PulseCO and the Vigileo devices obtain their signal by a standard peripheral arterial line. PulseCO measurements are based on harmonic waveform analysis (Fourier transformation) and integrate beat duration, ejection duration and mean arterial pressure; transpulmonary
Figure 1 Intermittent thermodilution: the Stewart-Hamilton principle
A, area of the thermodilution curve; C b , specific heat of blood; C i , specific heat of injectate; CO, cardiac output; C t , correction factor; K, calibration constant; S b , specific gravity of blood; S i , specific gravity of injectate; T b , blood temperature; T i , injectate temperature; V, injectate volume. Figure 2 Principle of cardiac output assessment by pulse contour analysis using the PiCCOplus system cal, specific calibration factor determined by transpulmonary thermodilution; CO, cardiac output; C( p), aortic compliance; dP/ dt, shape of the pressure wave curve; HR, heart rate; P(t)/SVR, area under the pressure wave curve; SVR, systemic vascular resistance. Reproduced with kind permission of Springer Science and Business Media. lithium indicator dilution (LiDCO) is used for calibration [15] . Compared with thermodilution, LiDCO is not temperature sensitive, but is influenced by electrolyte and hematocrit concentrations and allows only limited injections per time units. In contrast to the other systems, the FloTrac sensor attached to the Vigileo monitoring does not require external calibration. For CO assessment the standard deviation of pulse pressure measured during time windows of 20 s is empirically correlated to the 'normal' stroke volume based on underlying patient data. Aortic compliance is also estimated using these data, whereas resistance is derived by analyzing the actual pressure waveform characteristics. As a result of the primary principles used, all pulse contour devices share the inherent need of an optimal arterial signal quality for valid CO assessment. Arrhythmias and the use of an intraaortic balloon pump preclude reliable measurements. For the PiCCO system the insertion of the specific femoral catheter is contraindicated in patients with severe atheromatosis.
Pulse wave analysis devices -especially the PiCCO system -have been investigated extensively in the last decade and most studies have reported a good agreement with ITD. Inaccurate measurements as a result of variations in systemic vascular resistance were observed with the initial pulse contour algorithm [16] . The algorithm has been modified to better address the individual patient's aortic compliance and appears now to be more robust in situations of rapid hemodynamic changes [13, 17] . Evaluation of the PulseCO device revealed acceptable results in general [18, 19] . Agreement, however, showed considerable variation during different stages of cardiac surgery (mainly related to alterations in vascular compliance and resistance) [20] . Therefore, recalibration at intervals of 4-6 h, used to determine actual vascular status, may improve and maintain accuracy of CO readings, when changes of vascular resistance are likely to occur. Initial validation studies of the FloTrac/Vigileo device revealed conflicting results [14, 21] potentially related to a delayed adaptation of the vascular status [22] with the initial software. Studies using a software modified to better reflect the actual vascular status of the patient have not been published yet.
In addition to CO, devices analysing the pulse wave offer the possibility of a dynamic preload assessment: All devices display stroke volume variation as predictor of ventricular fluid responsiveness in mechanically ventilated patients [50] . Moreover, transpulmonary thermodilution used in the PiCCOplus allows the determination of global end-diastolic volume as volumetric preload variable [48] and of extravascular lung water, a prognostic factor in patients with sepsis and severe acute respiratory distress syndrome [51] .
Transesophageal echocardiography CO can be determined by transesophageal echocardiography (TEE) with a standard multiplane probe using the biplane application of the Simpson formula or by Doppler flow measurements. For the calculation according to the Simpson formula, the longitudinal axis and different end-systolic and diastolic left ventricular cross-sectional areas have to be determined and CO is derived from left ventricular volumes estimated on the basis of a cone-shaped geometric model. The more popular approach to CO assessment is to measure flow by pulsed-wave Doppler across a cardiac valve or in the left/right ventricular outflow tract and to assess the cross-sectional area at the site of the flow quantification (Fig. 3) . Prerequisites for optimal measurements are a Doppler beam orientation strictly parallel to the blood flow and an unchanged cross-sectional area over time. This is achieved best at the left ventricular outflow tract or the aortic valve in the transgastric probe position. TEE measurements are time consuming and require a high level of operator skills and knowledge. Moreover, the probe placement is not free of complications.
Variations of accuracy and agreement are mainly related to the inherent technical TEE problems (image quality, variations in orifice area determination, excessive Doppler beam angle) and the above assumptions for CO calculation [23, 24] . The automated CO measurement technique (ACOM) may have the potential to partly overcome these problems [25] . Multiple colour-flow Doppler measurements in a predefined valve area are used to measure CO without orifice area determination and time-consuming probe placement. The problem of observer variability, however, has not been solved yet.
Although TEE may not be used for routine CO monitoring, this visual technique allows a fast diagnostic assessment of ventricular function, wall motion abnormalities or cardiac filling with considerable therapeutic impact in acute, critical hemodynamic situations.
Transesophageal aortic Doppler ultrasound
Doppler flow measurements for CO estimation can also be performed in the descending aorta, where adequate characteristic flow signals due to the close proximity of the esophagus and the aorta can be obtained much more easily (Fig. 4) [52] . Special Doppler probes have been developed [ODMII (Abbott, Maidenhead, UK); CardioQ/Medicina TECO (Deltex Medical Ltd, Chichester, UK); HemoSonic100 (Arrow, Reading, Pennsylvannia, USA)] and CO is derived from measured aortic blood flow and aortic cross-sectional area obtained either from nomograms or by M-mode ultrasound determination (HemoSonic). Since coronary and brachiocephalic flows are not measured, CO is calculated assuming a constant partition between caudal and cephalic blood supply areas. The probes are smaller than conventional TEE probes and steep learning curves for probe positioning have been reported [53] . Clinical trials in the last few years have shown inconsistent results [26] [27] [28] [29] [30] [31] . Limited accuracy may result from signal detection problems, the assumption of fixed regional blood flow or the use of nomograms to determine aortic cross-sectional area. The HemoSonic 100 device was developed to eliminate the latter by echocardiographic aortic diameter measurement, but optimal adjustment of both the Doppler and the ultrasonic signal may be challenging.
The value of the esophageal Doppler technique is limited in clinical practice. The Doppler devices may be used in specific situations, however, by skilled observers. Based on the ability to reliably track CO changes over time early goal-directed therapy in a perioperative setting may be a typical indication, since different studies appear to demonstrate an improved outcome using this concept [4, 6] .
Partial carbon dioxide rebreathing
The NICO system (Novametrix Medical Systems, Wallingford, Connecticut, USA) uses Fick's principle applied to carbon dioxide (CO 2 ) for CO measurement (Fig. 5) . For CO 2 analysis, a mainstream infrared and airflow sensor is used. CO 2 production is calculated as the product of CO 2 concentration and air flow during a breathing cycle and arterial CO 2 content is derived from end-tidal CO 2 and the CO 2 dissociation curve. A disposable rebreathing loop allows an intermittent partial rebreathing state in cycles of 3 min. The rebreathing cycle induces an increase in end-tidal CO 2 and mimics a drop in CO 2 production. The obtained differences of these values are then used to calculate CO. Validation studies with conflicting results have been published in the last few years [7, [32] [33] [34] . Fairly good CO determination was observed as long as the NICO system was applied to intubated mechanically ventilated patients with minor lung abnormalities and fixed ventilatory settings. Variations in ventilatory modalities, mechanically assisted spontaneous breathing or use of this technique in patients with lung pathologies (increased shunt fraction), however, decreased accuracy of CO readings. Thus, the partial CO 2 rebreathing technique may be applied with good accuracy in a precisely defined clinical setting to mechanically ventilated patients only.
Pulsed dye densitometry
Pulsed dye densitometry by the DDG2001 analyzer (Nihon Kohden, Tokyo, Japan) allows intermittent CO measurement based on transpulmonary dye dilution with transcutaneous signal detection adapted from pulse oximetry. After venous injection of the dye -indocyanin green -its concentration is estimated in the arterial blood flow by optical absorbance measurements. CO is calculated from the observed dye dilution curve according to the Stewart-Hamilton principle. Israel)]. The most recently published clinical trials using TEB and WBEB, however, show conflicting results [38] [39] [40] [41] [42] . Therefore, this technique cannot be recommended for routine use.
Conclusion
The PAC can still be recommended for CO measurement in specific clinical situations, especially when additional monitoring of pulmonary artery pressures is desirable. Pulse wave analysis devices may be used alternatively and reliably in many clinical settings considering the specific properties of this technique. TEE and Doppler measurements may not be used for routine CO monitoring based on high operator dependency. Furthermore, TEE is rather considered a diagnostic point-of-care tool for critical hemodynamic situations than a CO monitoring device over time. Finally, the partial CO 2 rebreathing technique should be applied in a precisely defined clinical setting to mechanically ventilated patients only, and pulsed dye densitometry or the bioimpedance technique are currently limited to an investigational setting only.
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